Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
John A McCauley. (2005) NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004. Expert Opinion on Therapeutic Patents 15:4, pages 389-407.
Read now
Read now
Jinyang Hong, Eva Lee, Joi C. Carter, Jeff A. Masse & Darlene A. Oksanen. (2004) Antioxidant‐Accelerated Oxidative Degradation: A Case Study of Transition Metal Ion Catalyzed Oxidation in Formulation. Pharmaceutical Development and Technology 9:2, pages 171-179.
Read now
Read now
Trevor W Stone. (2001) Kynurenic acid antagonists and kynurenine pathway inhibitors. Expert Opinion on Investigational Drugs 10:4, pages 633-645.
Read now
Read now
Maria Elvira Tranquillini & Angelo Reggiani. (1999) Glycine-site antagonists and stroke. Expert Opinion on Investigational Drugs 8:11, pages 1837-1848.
Read now
Read now
Paul L Wood. (1998) NMDA antagonists for stroke and head trauma: current status. Expert Opinion on Investigational Drugs 7:9, pages 1505-1508.
Read now
Read now
Articles from other publishers (20)
Mohammadian Maryam & Bahaoddini Aminollah. (2023) IC87201, a PSD-95/nNOS Inhibitor, Ameliorates Heart Rate Variability in the Rat Model of Middle Cerebral Artery Occlusion. Insights in Biology and Medicine 7:1, pages 001-006.
Crossref
Crossref
Chuan Qin, Sheng Yang, Yun-Hui Chu, Hang Zhang, Xiao-Wei Pang, Lian Chen, Luo-Qi Zhou, Man Chen, Dai-Shi Tian & Wei Wang. (2022) Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Yu Diao, Weijie Yan, Wei Sun, Yanlin Luo, Junfa Li & Yanling Yin. (2018)
The dual role of KCNQ/M channels upon OGD or OGD/R insults in cultured cortical neurons of mice: Timing is crucial in targeting M‐channels against ischemic injur
ies
. Journal of Cellular Physiology 234:8, pages 12714-12726.
Crossref
Crossref
Qiu Jing Wu & Michael Tymianski. (2018) Targeting NMDA receptors in stroke: new hope in neuroprotection. Molecular Brain 11:1.
Crossref
Crossref
Cristobal de los Rios, Maria F. Cano-Abad, Mercedes Villarroya & Manuela G. López. (2017) Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds. Pflügers Archiv - European Journal of Physiology 470:1, pages 187-198.
Crossref
Crossref
Jessica A. Panzer, Amy J. Gleichman & David R. Lynch. (2014) Glutamatergic autoencephalitides: an emerging field. Journal of Neural Transmission 121:8, pages 957-968.
Crossref
Crossref
Sandra M. Vetiska & Michael Tymianski. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1381
1402
.
Manuela Mellone & Fabrizio Gardoni. (2013) Modulation of NMDA receptor at the synapse: Promising therapeutic interventions in disorders of the nervous system. European Journal of Pharmacology 719:1-3, pages 75-83.
Crossref
Crossref
Robert Meller. 2013. Innate Tolerance in the CNS. Innate Tolerance in the CNS
339
361
.
Andrew J Gauden, Veronica Pitt & Russell L Gruen. (2012) Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Aarti Sarwal, Muhammad Shazam Hussain & Ashfaq Shuaib. 2012. Translational Stroke Research. Translational Stroke Research
79
97
.
Ted Weita Lai, Woei-Cherng Shyu & Yu Tian Wang. (2011) Stroke intervention pathways: NMDA receptors and beyond. Trends in Molecular Medicine 17:5, pages 266-275.
Crossref
Crossref
Robert Meller & Roger P. Simon. 2008. Structural And Functional Organization Of The Synapse. Structural And Functional Organization Of The Synapse
731
758
.
Carmen Villmann & Cord-Michael Becker. (2007) On the Hypes and Falls in Neuroprotection: Targeting the NMDA Receptor. The Neuroscientist 13:6, pages 594-615.
Crossref
Crossref
Chandra Prakash, Donghui Cui, Michael J. Potchoiba & Todd Butler. (2007)
Metabolism, Distribution and Excretion of a Selective
N
-Methyl-d-Aspartate Receptor Antagonist, Traxoprodil, in Rats and Dogs
. Drug Metabolism and Disposition 35:8, pages 1350-1364.
Crossref
Crossref
Angela Angusti, Elisa Durini, Silvia Vertuani, Alessandro Dalpiaz, A. Ruffo, Romano Di Fabio, Daniele Donati, Giorgio Pentassuglia, Giovanni Vitulli, Robert J. Barnaby & Stefano Manfredini. (2005) Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor. Il Farmaco 60:5, pages 393-397.
Crossref
Crossref
Trevor W Stone. (2001) Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Progress in Neurobiology 64:2, pages 185-218.
Crossref
Crossref
Deborah A Dawson, Graham Wadsworth & Alan M Palmer. (2001) A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain Research 892:2, pages 344-350.
Crossref
Crossref
Alain Boireau, Carole Monterrat, Françoise Bordier, Mireille Meunier & Assunta Imperato. (2000) Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro. European Journal of Pharmacology 401:2, pages 131-135.
Crossref
Crossref
Trevor W Stone. (2000) Inhibitors of the kynurenine pathway. European Journal of Medicinal Chemistry 35:2, pages 179-186.
Crossref
Crossref